Speaking Engagements
 
Email Page
ACI 29th FDA Boot Camp
March 23, 2017

Axinn counsel Suchira Ghosh spoke about "Unique Considerations in the Approval of Combination Products, Companion Diagnostics, and Stem Cell Therapies," at ACI's 29th FDA Boot Camp in New York City.